Shorter biological marker length in aplastic anemia patients linked to higher relapse, death rates

Among patients receiving immunosuppressive therapy for severe aplastic anemia (a condition in which the bone marrow is unable to produce blood cells), the length of telomeres (chromosome markers of biological aging) was not related to the response to treatment but was associated with a higher rate of relapse (return to low blood cell counts) and lower overall survival, according to a new study.

Read the whole article on Science Daily

More from Science Daily